Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uterosacral Bupivacaine for Post-Hysterectomy Pain
NCT04157075Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Difference in post-operative opioid usage. Started Mar 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04157075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04157075.